MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
0.7173
-0.0007 (-0.10%)
Jul 11, 2025, 9:30 AM - Market open
MetaVia Market Cap
MetaVia has a market cap or net worth of $14.05 million as of July 11, 2025. Its market cap has decreased by -29.39% in one year.
Market Cap
14.05M
Enterprise Value
2.99M
1-Year Change
-29.39%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since August 5, 2016, MetaVia's market cap has decreased from $84.50M to $14.05M, a decrease of -83.37%. That is a compound annual growth rate of -18.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 13.50M | -22.86% |
| Dec 31, 2024 | 17.50M | -2.23% |
| Dec 29, 2023 | 17.90M | 280.85% |
| Dec 30, 2022 | 4.70M | -85.49% |
| Dec 31, 2021 | 32.40M | -62.41% |
| Dec 31, 2020 | 86.20M | 1,557.69% |
| Dec 31, 2019 | 5.20M | -55.17% |
| Dec 31, 2018 | 11.60M | -86.27% |
| Dec 29, 2017 | 84.50M | 16.23% |
| Dec 30, 2016 | 72.70M | -13.96% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |